Compare Sastasundar Ven. with Similar Stocks
Stock DNA
Healthcare Services
INR 940 Cr (Micro Cap)
36.00
23
0.00%
0.01
0.01%
1.36
Total Returns (Price + Dividend) 
Latest dividend: 1 per share ex-dividend date: Jul-23-2012
Risk Adjusted Returns v/s 
Returns Beta
News

Sastasundar Ventures Ltd is Rated Sell
Sastasundar Ventures Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 06 February 2026. However, the analysis and financial metrics discussed below reflect the stock's current position as of 13 February 2026, providing investors with the latest insights into the company’s fundamentals, valuation, financial trends, and technical outlook.
Read full news article
Sastasundar Ventures Ltd Valuation Shifts to Very Expensive Amid Mixed Returns
Sastasundar Ventures Ltd, a key player in the Healthcare Services sector, has witnessed a marked shift in its valuation parameters, moving from a risky to a very expensive rating. Despite a modest share price decline of 0.45% on 10 Feb 2026, the company’s price-to-earnings (P/E) and price-to-book value (P/BV) ratios have surged, raising questions about its price attractiveness relative to historical and peer benchmarks.
Read full news articleAre Sastasundar Ventures Ltd latest results good or bad?
Sastasundar Ventures Ltd's latest financial results reveal a complex operational landscape characterized by both revenue growth and significant profitability challenges. In the second quarter of FY26, the company reported net sales of ₹301.32 crores, reflecting a year-on-year increase of 10.16% and a marginal sequential growth of 0.97%. This indicates a degree of resilience in top-line performance, particularly when compared to the broader healthcare services sector, which has shown stronger growth. However, the company's consolidated net profit for the same quarter was a loss of ₹12.69 crores, marking a dramatic decline from profitability in the previous quarter and a substantial year-on-year deterioration. The operating margin, excluding other income, fell to -7.50%, highlighting severe operational inefficiencies. This loss of profitability is concerning, especially given that the company has recorded ne...
Read full news article Announcements 
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
09-Feb-2026 | Source : BSEPlease find the submission of Audio recording of the Earnings Conference call for Q3 FY26.
Announcement under Regulation 30 (LODR)-Newspaper Publication
07-Feb-2026 | Source : BSEPlease find attached the copy of Newspaper publication of the Unaudited Financial Results for the quarter and nine months ended 31st December 2025
Results - Unaudited Financial Results For The Quarter And Nine Months Ended 31St December 2025
06-Feb-2026 | Source : BSEPlease find attached the Outcome of Board Meeting held today 6th February 2026
Corporate Actions 
No Upcoming Board Meetings
Sastasundar Ventures Ltd has declared 10% dividend, ex-date: 23 Jul 12
No Splits history available
No Bonus history available
No Rights history available
Quality key factors 
Valuation key factors
Technicals key factors
Shareholding Snapshot : Dec 2025
Shareholding Compare (%holding) 
Promoters
None
Held by 2 Schemes (0.0%)
Held by 5 FIIs (2.25%)
Banwari Lal Mittal (33.76%)
Lekh Raj Juneja (1.89%)
12.72%
Quarterly Results Snapshot (Consolidated) - Dec'25 - YoY
YoY Growth in quarter ended Dec 2025 is 22.91% vs -24.89% in Dec 2024
YoY Growth in quarter ended Dec 2025 is 104.19% vs -3,492.00% in Dec 2024
Annual Results Snapshot (Consolidated) - Mar'25
YoY Growth in year ended Mar 2025 is -19.66% vs 30.60% in Mar 2024
YoY Growth in year ended Mar 2025 is -2,382.74% vs 105.88% in Mar 2024






